Drug surveillance of new antidepressants;La pharmacovigilance des nouveaux antidepresseurs

Therapie

Volumn 52, Issue 2, 1997, Pages 117-122

  Blayac, J P ^a   Hillaire Buys, D ^a   Peyriere H ^a  

^a MONTPELLIER UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINEPTINE; ANTIDEPRESSANT AGENT; FLUOXETINE; FLUVOXAMINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR;

COGNITIVE DEFECT; DRUG MONITORING; DRUG SURVEILLANCE PROGRAM; DRUG WITHDRAWAL; HUMAN; MENTAL DISEASE; PRIORITY JOURNAL; REVIEW; TERATOGENICITY; ARTICLE; BEHAVIOR; BRAIN DISEASE; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; FEMALE; POSTMARKETING SURVEILLANCE; PREGNANCY;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BEHAVIOR; BRAIN DISEASES; COGNITION DISORDERS; FEMALE; FLUOXETINE; HUMANS; PREGNANCY; PRODUCT SURVEILLANCE, POSTMARKETING;

EID: 0030887170     PISSN: 00405957     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Lefebure B, Castot A, Danan G et al. Hépatites aux antidépresseurs. Bilan des observations de l'Association Française des Centres de Pharmacovigilance et de la Commission Technique. Thearapie 1984; 39: 509-516.
2. Castot A, Benzaken C, Wagniart F, Efthymiou ML. Surconsommation d'amineptine. Therapie 1990; 45: 399-405.
3. Sternbach H. The serotonin syndrome. Am J Psychiatry 1991; 148: 705-713.
4. Brown TM, Skop BP, Mareth TR. Pathophysiology and management of the serotonin syndrome. Ann Pharmacother 1996; 30: 527-533.
5. Lazowick AL, Levin GM. Potential withdrawal syndrome associated with SSRI discontinuation. Ann Pharmacother 1995; 29: 1284-1285.
6. Price JS, Waller PC, Wood SM, Mackay AVP. A comparison of the post-marketing safety of four selective serotonin re-uptake inhibitors including the investigation of the symptoms occuring on withdrawal. Br J Clin Pharmacol 1996; 42: 757-763.
7. Kerns LL. Treatment of mental disorders in pregnancy. J Nerv Ment Diseases 1986; 174: 652-659.
8. Spreux A, Chichmanian RM, Jean-Girard C, Nouchi J. Enquête prospective OMEGA (Observatoire Azuréen Médicament-Grossesse). Therapie 1991; 46: 369-372.
9. Altshuler LL, Cohen L, Szuha MP et al. Pharmacologic management of psychiatric illness during pregnancy: dilemmas and guidelines. Am J Psychiatry 1996; 153: 592-606
10. Pastuszak A, Schick-Boschetto B, Zuber C et al. Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac). JAMA 1993; 269: 2246-2248.
11. Rosa FW. Medicaid antidepressant pregnancy exposure outcomes. Reprod Toxicol 1994; 8: 444.
12. Goldstein DJ. Effect of third trimester fluoxetine exposure on the newborn. J Clin Psychopharmacol 1995; 15: 417-420.
13. Nulman I, Rovet J, Stewart D et al. Neurodevelopment of children exposed to fluoxetine in utero: a prospective longitudinal study. Clin Pharmacol Ther 1995; 59: 159.
14. McElhatton PR, Garbis HM, Eléfant E et al. The outcome of pregnancy in 689 women exposed to therapeutic doses of antidepressants. A collaborative study of the European Network of Teratology Information Services (ENTIS). Reprod Toxicol 1996; 10: 285-294.
15. Chambers CD, Johnson KA, Dick LM et al. Birth outcomes in pregnant women taking fluoxetine. N Engl J Med 1996; 335: 1010-1015.
16. Robert E. Treating depression in pregnancy. N Engl J Med 1996; 335: 1056-1058.
17. Misri S, Sivertz K. Tricyclic drugs in pregnancy and lactation: a preliminary report. Int J Psychiatry Med 1991; 21: 157-171.
18. Weissman M. Epidémiologie de la dépression majeure et de la psychose bipolaire: étude internationale. Neuro-psy 1994; No spécial décembre: 8-17.
19. Hindmarch I, Barwell, Alford C. Behavioural toxicity of antidepressants. In: Leonard B, Spencer P, eds. Antidepressants: thirty years on. London: CNS Publishers, 1990: 403-409.
20. Scotto JC. La durée des traitements de la dépression. IVè Colloque de Marseille. Encephale 1995; XXI (No Spécial II) : 78PP.
21. Amado-Boccara I, Galinowski A, Poirier MF, Lôo H. Influence des psychotropes sur la vigilance et les performances motrices. Presse Med 1992; 21: 899-902.